Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
3,283,246
-
Total 13F shares
-
197,515
-
Share change
-
+81,174
-
Total reported value
-
$491,813
-
Price per share
-
$2.49
-
Number of holders
-
8
-
Value change
-
+$202,123
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) as of Q3 2024
As of 30 Sep 2024,
AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
197,515 shares.
The largest 8 holders included
ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Moss Adams Wealth Advisors LLC, UBS Group AG, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.